Overall impact
A (82)

Commentary

Procyon is a leader for overall positive impact. With an 'A' rating of 81.9 for overall impact (95th percentile compared to all companies), Procyon ranks 26th out of 585 industry peers, behind Regeneron Pharmaceuticals, Cell Source, Clementia Pharmaceuticals and 22 others, and ahead of Grifols, Biogen, Ionis Pharmaceuticals and 556 others. On top material causes for Procyon's industry (Pharmaceuticals & Biotech), Procyon performs well in Improved Mental Health (90.1 score), Child and Maternal Health (94.6), Humane Treatment of Animals (95.6) and 8 other causes where it received an 'A' score and performs poorly in Technology Innovation (18.8 score) and Reduced Green House Gas Emissions (32.9).
Impact
Cause PCYN
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company

Procyon

Employees
19
Sector
Health Care
Industry
Biotechnology
Sub-industry
Biotechnology
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Fl, United States
Share classes
PCYN
Description
Procyon Corporation, together with its subsidiaries, manufactures and markets wound and skin care products primarily in the United States. It provides AMERIGEL, an advanced skin and wound care product line, including hydrogel wound dressing, post-op surgical kits, saline wound washes, and care and barrier lotions. The company also offers HELIX3 Bioactive Collagen products, such as collagen powder, gel, and matrix, as well as calcium alginate dressing, foam dressing, AMERX gauze dressing, hydrocolloid dressing, and wound care kits that include calcium alginate, collagen matrix, collagen powder, foam, hydrogel, and rolled gauze wound care kits under the AMERX brand. Additionally, Procyon Corporation provides AMERIGEL hand sanitizer; EXTREMIT-EASE compression garment products; Advantagen, a surgical collagen powder that promotes wound closure and reduces the potential for surgical site infection; calcium alginate, foam, and gauze dressings; retention tapes; and Helix collagen gel. The company sells its products to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, physicians, and other health care practitioners. It also serves retail customers through distributors, direct and internet sales, as well as through independent and retail chain drug stores. Procyon Corporation was incorporated in 1987 and is based in Oldsmar, Florida.
Material causes
Ethos considers the following causes material for Procyon, based on its industry sub-industry Biotechnology. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.